|
ABOUT COMPANY
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of small molecule therapies for the treatment of cancer patients. The company is headquartered in Research Triangle Park, North Carolina.
|
EARNINGS
Gross Profit (TTM): 45285000
Market Capitalization: 454561000
Operating Margin (TTM): -3.054
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 1.034
Revenue (TTM): 42226000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.817
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.275
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -105136000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|